Team Envy and Dignitas each won their "Last-Chance Stage" matches on Sunday to advance to the playoffs of the Flashpoint Season 2 event.

Envy, which had finished in fourth place in Group B during group-stage play, pulled off a reverse sweep vs. Gen.G Esports, who finished third in Group C. After dropping the first map 16-8 on Train, Envy rallied back to win 16-13 on Nuke followed by a dominating 16-3 win on Dust II.

Turkey's Bugra "Calyx" Arkin led the way for Envy's international squad, with 62 kills and plus-19 kills-to-death differential. Poland's Michal "MICHU" Muller added 56 kills and a plus-8 differential.

Also Sunday, Dignitas -- who finished third in Group A -- faced a similar battle against forZe, who placed third in Group B. After losing 16-9 on Inferno, Dignitas won 1-4 on Nuke and 16-14 on Dust II.

Sweden's Ludvig "HEAP" Alonso paced Dignitas with 60 kills and a plus-17 kills-to-death differential. Teammate Hakon "hallzerk" Fjaerli followed up with 52 kills and a net-zero differential.

The Counter-Strike: Global Offensive event began with 12 teams divided into three groups for opening-round, double-elimination play. The top two teams in each group advanced to the upper bracket of the double-elimination playoffs. The three third-place teams and the fourth-place team with the best record were part of the last-chance stage.

MAD Lions,, BIG, Fnatic, OG and MIBR previously qualified for the double-elimination playoffs.

All matches are best-of-three, including the final on Dec. 6. The championship team will receive $500,000 and 3,000 BLAST Premier points.

Flashpoint Season 2 prize pool, with money and BLAST Premier points:

1. TBD -- $500,000, 3,000 points

2. TBD -- $250,000, 1,500 points

3. TBD -- $100,000, 1,125 points

4. TBD -- $50,000, 750 points

5-6. TBD -- $35,000, 375 points

7-8. TBD -- $15,000, 188 points

9. Gen.G Esports -- no money, no points

10. forZe -- no money, no points

11. c0ntact Gaming -- no money, no points

12. Cloud9 -- no money, no points

--Field Level Media

Stay Informed

(0) comments

Welcome to the discussion.

Please log in, or sign up for a new, free account to read or post comments.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.